Home
Shionogi B.V.

Shionogi B.V. Market Share Analysis for March 2026

Shionogi Inc. is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs.

Industry: N/A

Domainshionogi.eu

Year Founded2012

Employees5001 - 10000

Annual Revenue> $1B

Shionogi B.V.

Shionogi B.V. (including company regionals)

shionogi.eu

See more website traffic and engagement information

Shionogi B.V. Revenue up to March 2026 is > 1B

revenue generated by Shionogi B.V. top domains

Shionogi B.V. top domains revenue over 3 years

Revenue for Shionogi B.V. top domains

shionogi.eu> 1B

See more with Sales Intelligence

Total visits to Shionogi B.V.'s top domains

Understand Shionogi B.V. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Shionogi B.V.'s top domains

Analyze Shionogi B.V. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Shionogi B.V.'s top domains

See how Shionogi B.V. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Shionogi B.V. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Shionogi B.V.

These are the website technologies, by industry, used by Shionogi B.V. top domains

Mobile (2)

Meta Viewport

Payment & Currencies (2)

Euro

Advertising (1)

DoubleClick

Audio Video Media (1)

Vimeo

More Technologies

9

See all

News & Signals from Shionogi B.V.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsShionogi launches third-phase clinical trials in the U.S..Shionogi has launched third-phase clinical trials in the U.S.

NewsShionogi launches Peramivir to the market.Based on results from the joint pre-clinical research with Hokkaido University, Shionogi has introduced Peramivir to the market.